Immune monitoring in small bowel transplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 3, 2010, Pages 349-356

  Sindhi, Rakesh ^a,b   Ashokkumar, Chethan ^a,b   Mazariegos, George ^a,b   Nayyar, Navdeep ^a,b   Ningappa, Mylarappa ^a,b   Soltys, Kyle ^a,b   Bond, Geoffrey ^a,b   Sun, Qing ^a,b   Humar, Abhinav ^b   Abu Elmagd, Kareem ^b   Zeevi, Adriana ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dendritic cells; Donor specific antibodies; Immune monitoring; Nucleotide binding oligomerization protein genes; Panel reactive antibodies; Pediatric; Small bowel transplantation; T cell alloreactivity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALGRANULIN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD40 LIGAND; HLA ANTIBODY; HLA ANTIGEN; MACROPHAGE ACTIVATING FACTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; OKT 3; STEROID;

ACUTE GRAFT REJECTION; ANTIBODY DETECTION; ANTIGEN EXPRESSION; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CYTOTOXICITY TEST; DENDRITIC CELL; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GRAFT FAILURE; GRAFT RECIPIENT; HELPER CELL; HLA MATCHING; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE BIOPSY; INTESTINE TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION;

BIOLOGICAL ASSAY; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG MONITORING; GENETIC MARKERS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; INTESTINE, SMALL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MONITORING, IMMUNOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; SHORT BOWEL SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953236767     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328339489c     Document Type: Review

References (27)

1. Murray J, Merrill J, Harrison J. Renal homotransplantation in identical twins. J Am Soc Nephrol 2001; 12:201-204; Reprinted from Surg Forum VI 1955:432-436.
2. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280:735-739.
3. Bach F, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964; 143:813-814.
4. Curtoni ES, Mattiuz PL, Tosi RM, editors. Histocompatibility testing 1967. Third International Histocompatibility Workshop and Conference (1967 Turin, Italy and Saint-Vincent, Italy); Munksgaard, Copenhagen; 1967.
5. Park I, Terasaki P. Origins of the first HLA specificities. Hum Immunol 2000; 61:185-189.
6. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001; 234:404-417.
7. Nayyar N, Mazariegos G, Ranganathan S, et al. Pediatric small bowel transplantation. Semin Pediatr Surg 2010; 19:68-77.
8. UNOS OPTN Annual Report, 2008. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 2008. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, Maryland, USA; United Network forOrgan Sharing, Richmond, Virginia, USA; University Renal Research and Education Association, Ann Arbor, Michigan, USA.
9. Reyes J, Mazariegos GV, Abu-Elmagd K, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit antithymocyte globulin (thymoglobulin). Am J Transplant 2005; 5:1430-1436.
10. Ting A. Positive crossmatches: when is it safe to transplant? Transplant Int 1989; 2:2-7.
11. Khodadadi L, Adib M, Pourazar A. Immunoglobulin class (IgG, IgM) determination by dithiothreitol in sensitized kidney transplant candidates. Transplant Proc 2006; 38:2813-2815.
12. Talukdar A, AshokKumar C, Wilson P, et al. Lymphocyte subset reconstitution patterns in children with small bowel transplantation (SBTX) induced with steroid-free rabbit antihuman thymocyte globulin. Pediatr Transplant 2009; 13:353-359.
13. Zeevi A, Britz JA, Bentlejewski CA, et al. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transpl Immunol 2005; 15:17-24.
14. Gupta A, AshokKumar C, Ningappa M, et al. Elevated myeloid:plasmacytoid dendritic cell ratio associates with early acute cellular rejection in pediatric small bowel transplantation. Transplantation 2010; 89:55-60.
15. Gebauer BS, Hricik DE, Atallah A, et al. Evolution of the enzyme-linked immunosorbent spot assay for posttransplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2:857-866.
16. AshokKumar C, Gupta A, Sun Q, et al. Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with small-bowel transplantation. Transplantation (in press).
17. + T Cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 2009; 9:179-191.
18. + T-cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery 2009; 146:166-173.
19. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by Ts cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3:237-243.
20. +CD28 T-suppressor cells. Hum Immunol 2005; 66:252-257.
21. Sudan D, Vargas L, Sun Y, et al. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246:311-315.
22. Akpinar E, Vargas J, Kato T, et al. Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study. Transplantation 2008; 85:1281-1286.
23. Peyrin-Biroulet L, Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007; 13:135-139.
24. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5:800-808.
25. Fishbein T, Novitskiy G, Mishra L, et al. NOD2-expressing bone marrowderived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2008; 57:323-330.
26. Weersma JM, Festen EAM, Sudan DL, et al. The role of genetic disease susceptibility loci in small bowel transplant outcome. Presented at the International Small Bowel Transplant Symposium; 14 September 2009; Bologna, Italy.
27. Hirschhorn JN, Lohmueller K, Byrne E, Hirschorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4:45-61.